Historical Stock Price
LIFE historical stock prices picture
aTyr Pharma (LIFE) has the following price history information. Looking back at LIFE historical stock prices for the last five trading days, on April 17, 2024, LIFE opened at $1.64, traded as high as $1.64 and as low as $1.58, and closed at $1.59. Trading volume was a total of 537.20K shares. On April 18, 2024, LIFE opened at $1.60, traded as high as $1.64 and as low as $1.58, and closed at $1.62. Trading volume was a total of 276.50K shares. On April 19, 2024, LIFE opened at $1.65, traded as high as $1.65 and as low as $1.58, and closed at $1.60. Trading volume was a total of 159.10K shares. On April 22, 2024, LIFE opened at $1.60, traded as high as $1.69 and as low as $1.57, and closed at $1.64. Trading volume was a total of 293.50K shares. On April 23, 2024, LIFE opened at $1.68, traded as high as $1.69 and as low as $1.61, and closed at $1.62. Trading volume was a total of 221.50K shares.

LIFE Historical Stock Prices By Date:

LIFE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into aTyr Pharma shares, starting with a $10,000 purchase of LIFE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/08/2015
End date: 04/23/2024
Start price/share: $269.78
End price/share: $1.62
Dividends collected/share: $0.00
Total return: -99.40%
Average Annual Total Return: -43.47%
Starting investment: $10,000.00
Ending investment: $60.07
Years: 8.97
Date Open High Low Close Volume
04/17/2024 $1.64 $1.64 $1.58 $1.59 537.20K
04/18/2024 $1.60 $1.64 $1.58 $1.62 276.50K
04/19/2024 $1.65 $1.65 $1.58 $1.60 159.10K
04/22/2024 $1.60 $1.69 $1.57 $1.64 293.50K
04/23/2024 $1.68 $1.69 $1.61 $1.62 221.50K
aTyr Pharma is a biotherapeutics company engaged in the discovery and development of medicines based on biological pathways. Co.'s primary therapeutic candidate efzofitimod, which is a fusion protein comprised of the immunomodulatory domain of histidyl-tRNA synthetase fused to the fragment crystallizable region of a human antibody. In parallel with Co.'s clinical development of efzofitimod, Co. has been improving its discovery pipeline of NRP2 antibodies and tRNA synthetases. Co.'s investigational new drug candidate ATYR2810, which is a humanized monoclonal antibody that blocks the interaction between NRP2 and one of its primary ligands, vascular endothelial growth factor.
Date Close
04/17/2024$1.59
04/18/2024$1.62
04/19/2024$1.60
04/22/2024$1.64
04/23/2024$1.62
LIFE is categorized under the Healthcare sector; below are some other companies in the same sector:

LJPC Historical Stock Prices
LLY Historical Stock Prices
LMAT Historical Stock Prices
LMNX Historical Stock Prices
LNTH Historical Stock Prices
LOXO Historical Stock Prices
LPCN Historical Stock Prices
LPDX Historical Stock Prices
LPNT Historical Stock Prices
LPTN Historical Stock Prices

Also explore: LIFE shares outstanding history

Email EnvelopeFree LIFE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


LIFE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.